Phase 1 / 2 Study of SAR439859 Single Agent and in Combination With Palbociclib in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer (AMEERA-1)
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: Breast Cancer
Age: Between 18 - 100 Years
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required